Literature DB >> 11801453

T-cell education in autoimmune diabetes: teachers and students.

Judith G M Rosmalen1, Willem van Ewijk, Pieter J M Leenen.   

Abstract

Type 1 diabetes mellitus is a classical example of a T-cell-mediated autoimmune disease. Several aberrations in immune regulation have been described in both human diabetes patients and animal models of type 1 diabetes. In this review, we summarize how proposed immune defects might be implicated in the loss of T-cell tolerance towards self in autoimmune diabetes in humans, nonobese diabetic (NOD) mice and Biobreeding (BB) rats. For this purpose, we will discuss the tolerance-inducing mechanisms that an autoreactive T cell should encounter from its genesis to its pathogenic role in the pancreas, in order of appearance. These comprise central tolerance mechanisms (i.e. positive and negative selection in the thymus) and those mechanisms operative in the periphery (i.e. activation-induced cell death and regulatory T cells).

Entities:  

Mesh:

Year:  2002        PMID: 11801453     DOI: 10.1016/s1471-4906(01)02088-9

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  12 in total

Review 1.  Immunology in the clinic review series; focus on type 1 diabetes and viruses: enterovirus, thymus and type 1 diabetes pathogenesis.

Authors:  H Jaïdane; F Sané; R Hiar; A Goffard; J Gharbi; V Geenen; D Hober
Journal:  Clin Exp Immunol       Date:  2012-04       Impact factor: 4.330

Review 2.  Novel diabetes autoantibodies and prediction of type 1 diabetes.

Authors:  Janet M Wenzlau; John C Hutton
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

3.  Alterations in immune cell subsets and their cytokine secretion profile in childhood idiopathic thrombocytopenic purpura (ITP).

Authors:  R M Talaat; A M Elmaghraby; S S Barakat; M El-Shahat
Journal:  Clin Exp Immunol       Date:  2014-05       Impact factor: 4.330

4.  Increased transcriptional preproinsulin II beta-cell activity in neonatal nonobese diabetic mice: in situ hybridization analysis.

Authors:  Marc Throsby; Josiane Coulaud; Sylvie Durant; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-08-10

5.  Tolerance induction and endogenous regeneration of pancreatic beta-cells in established autoimmune diabetes.

Authors:  Charles Sia; Francoise Homo-Delarche
Journal:  Rev Diabet Stud       Date:  2005-02-10

6.  A functional polymorphism in the promoter/enhancer region of the FOXP3/Scurfin gene associated with type 1 diabetes.

Authors:  Wafaa M Bassuny; Kenji Ihara; Yuka Sasaki; Ryuichi Kuromaru; Hitoshi Kohno; Nobuo Matsuura; Toshiro Hara
Journal:  Immunogenetics       Date:  2003-05-16       Impact factor: 2.846

7.  Characterization of the peptide binding specificity of the HLA class I alleles B*38:01 and B*39:06.

Authors:  John Sidney; Jennifer Schloss; Carrie Moore; Mikaela Lindvall; Amanda Wriston; Donald F Hunt; Jeffrey Shabanowitz; Teresa P DiLorenzo; Alessandro Sette
Journal:  Immunogenetics       Date:  2016-01-11       Impact factor: 3.330

8.  Immunomodulatory strategies prevent the development of autoimmune emphysema.

Authors:  Masayuki Hanaoka; Mark R Nicolls; Andrew P Fontenot; Donatas Kraskauskas; Douglas G Mack; Adelheid Kratzer; Jonas Salys; Vita Kraskauskiene; Nana Burns; Norbert F Voelkel; Laimute Taraseviciene-Stewart
Journal:  Respir Res       Date:  2010-12-16

9.  A defect in tryptophan catabolism impairs tolerance in nonobese diabetic mice.

Authors:  Ursula Grohmann; Francesca Fallarino; Roberta Bianchi; Ciriana Orabona; Carmine Vacca; Maria C Fioretti; Paolo Puccetti
Journal:  J Exp Med       Date:  2003-06-30       Impact factor: 14.307

10.  Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.

Authors:  Maria Teresa Pallotta; Ciriana Orabona; Roberta Bianchi; Carmine Vacca; Francesca Fallarino; Maria Laura Belladonna; Claudia Volpi; Giada Mondanelli; Marco Gargaro; Massimo Allegrucci; Vincenzo Nicola Talesa; Paolo Puccetti; Ursula Grohmann
Journal:  J Cell Mol Med       Date:  2014-09-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.